Statistical analysis also revealed a positive correlation between BCL-2 expression and the presence of ER and PR receptors, suggesting that BCL-2 may be a marker of favorable prognosis, particularly in hormone-dependent types of breast cancer. Here, BCL2 is linked to breast cancer.